These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 2204444)
1. Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity. Goormaghtigh E; Huart P; Praet M; Brasseur R; Ruysschaert JM Biophys Chem; 1990 Apr; 35(2-3):247-57. PubMed ID: 2204444 [TBL] [Abstract][Full Text] [Related]
2. Evidence of a complex between adriamycin derivatives and cardiolipin: possible role in cardiotoxicity. Goormaghtigh E; Chatelain P; Caspers J; Ruysschaert JM Biochem Pharmacol; 1980 Nov; 29(21):3003-10. PubMed ID: 7458950 [No Abstract] [Full Text] [Related]
3. Adriamycin as a probe for the transversal distribution of cardiolipin in the inner mitochondrial membrane. Cheneval D; Müller M; Toni R; Ruetz S; Carafoli E J Biol Chem; 1985 Oct; 260(24):13003-7. PubMed ID: 4055730 [TBL] [Abstract][Full Text] [Related]
4. Effects of adriamycin on lipid polymorphism in cardiolipin-containing model and mitochondrial membranes. Nicolay K; van der Neut R; Fok JJ; de Kruijff B Biochim Biophys Acta; 1985 Sep; 819(1):55-65. PubMed ID: 4041451 [TBL] [Abstract][Full Text] [Related]
5. Study of the adriamycin-cardiolipin complex structure using attenuated total reflection infrared spectroscopy. Goormaghtigh E; Brasseur R; Huart P; Ruysschaert JM Biochemistry; 1987 Mar; 26(6):1789-94. PubMed ID: 3593690 [TBL] [Abstract][Full Text] [Related]
6. The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes. Nicolay K; Timmers RJ; Spoelstra E; Van der Neut R; Fok JJ; Huigen YM; Verkleij AJ; De Kruijff B Biochim Biophys Acta; 1984 Dec; 778(2):359-71. PubMed ID: 6498197 [TBL] [Abstract][Full Text] [Related]
7. In vivo prevention of adriamycin cardiotoxicity by cyclosporin A or FK506. Al-Nasser IA Toxicology; 1998 Nov; 131(2-3):175-81. PubMed ID: 9928632 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of inhibition of mitochondrial enzymatic complex I-III by adriamycin derivatives. Goormaghtigh E; Huart P; Brasseur R; Ruysschaert JM Biochim Biophys Acta; 1986 Sep; 861(1):83-94. PubMed ID: 3019400 [TBL] [Abstract][Full Text] [Related]
9. Evidence of a covalent linkage in the adriamycin-cardiolipin complex induced by adriamycin-mediated electron transport. Goormaghtigh E; Ruysschaert JM Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):149-52. PubMed ID: 6316434 [TBL] [Abstract][Full Text] [Related]
10. The exogenous NADH dehydrogenase of heart mitochondria is the key enzyme responsible for selective cardiotoxicity of anthracyclines. Nohl H; Gille L; Staniek K Z Naturforsch C J Biosci; 1998; 53(3-4):279-85. PubMed ID: 9618942 [TBL] [Abstract][Full Text] [Related]
11. Mitochondria-specific nano-emulsified therapy for myocardial protection against doxorubicin-induced cardiotoxicity. Faulk A; Weissig V; Elbayoumi T Methods Mol Biol; 2013; 991():99-112. PubMed ID: 23546663 [TBL] [Abstract][Full Text] [Related]
12. Role of cardiolipin in the functioning of mitochondrial L-glycerol-3-phosphate dehydrogenase. Beleznai Z; Jancsik V Biochem Biophys Res Commun; 1989 Feb; 159(1):132-9. PubMed ID: 2923620 [TBL] [Abstract][Full Text] [Related]
13. Identification of the site of adriamycin-activation in the heart cell. Nohl H Biochem Pharmacol; 1988 Jul; 37(13):2633-7. PubMed ID: 3390223 [TBL] [Abstract][Full Text] [Related]
14. Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Rajagopalan S; Politi PM; Sinha BK; Myers CE Cancer Res; 1988 Sep; 48(17):4766-9. PubMed ID: 2842038 [TBL] [Abstract][Full Text] [Related]
15. Antibody-independent activation of the complement system by mitochondria is mediated by cardiolipin. Peitsch MC; Tschopp J; Kress A; Isliker H Biochem J; 1988 Jan; 249(2):495-500. PubMed ID: 3277626 [TBL] [Abstract][Full Text] [Related]
16. Binding of adriamycin-Fe3+ complex to membrane phospholipids. Demant EJ Eur J Biochem; 1984 Aug; 142(3):571-5. PubMed ID: 6468379 [TBL] [Abstract][Full Text] [Related]
17. Interaction of carnitine with mitochondrial cardiolipin. Battelli D; Bellei M; Arrigoni-Martelli E; Muscatello U; Bobyleva V Biochim Biophys Acta; 1992 Jul; 1117(1):33-6. PubMed ID: 1627589 [TBL] [Abstract][Full Text] [Related]
18. Abrogation of the selectivity of adriamycin for negatively-charged phospholipids by 14-valerate side chain substitution. Burke TG; Israel M; Seshadri R; Doroshow JH Cancer Biochem Biophys; 1990 Apr; 11(2):177-85. PubMed ID: 2383860 [TBL] [Abstract][Full Text] [Related]
19. Effect of adriamycin on the activity of the succinate dehydrogenase-coenzyme Q10 reductase of the rabbit myocardium. Bertazzoli C; Sala L; Ballerini L; Watanabe T; Folkers K Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):797-800. PubMed ID: 1005920 [TBL] [Abstract][Full Text] [Related]
20. A possible mechanism of adriamycin cardiotoxicity. Inhibition of NADP-linked isocitrate dehydrogenase. Minaga T; Yasumi M; Nakamura K; Kimura I; Kizu A; Ijichi H Adv Myocardiol; 1983; 4():247-53. PubMed ID: 6856959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]